Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Covey

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|June 19, 1998
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal applicationO M Howard, J J Oppenheim, M G Hollingshead, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductaseJulianne L Holleran, Julien Fourcade, Merrill J Egorin, et al.
AJR. American Journal of Roentgenology|September 22, 2007
Radiofrequency ablation in the management of liver metastases from breast cancerC T Sofocleous, R G Nascimento, M Gonen, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer InstituteG J Kelloff, J A Crowell, C W Boone, et al.
Journal of the American College of Surgeons|June 1, 2010
Current management of pyogenic liver abscess: surgery is now second-line treatmentJames J Mezhir, Yuman Fong, Lindsay M Jacks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularineJulianne L Holleran, Robert A Parise, Erin Joseph, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 12, 2016
Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer PatientsHooman Yarmohammadi, Lynn A Brody, Joseph P Erinjeri, et al.
Annals of Surgery|April 1, 2008
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastasesAnne M Covey, Karen T Brown, William R Jarnagin, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 4, 2011
Pyogenic abscess after hepatic artery embolization: a rare but potentially lethal complicationJames J Mezhir, Yuman Fong, Deborah Fleischer, et al.
Surgical Endoscopy|January 31, 2013
Management of peripancreatic fluid collections following partial pancreatectomy: a comparison of percutaneous versus EUS-guided drainageYong M Kwon, Hans Gerdes, Mark A Schattner, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|June 19, 1998
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal applicationO M Howard, J J Oppenheim, M G Hollingshead, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductaseJulianne L Holleran, Julien Fourcade, Merrill J Egorin, et al.
AJR. American Journal of Roentgenology|September 22, 2007
Radiofrequency ablation in the management of liver metastases from breast cancerC T Sofocleous, R G Nascimento, M Gonen, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer InstituteG J Kelloff, J A Crowell, C W Boone, et al.
Journal of the American College of Surgeons|June 1, 2010
Current management of pyogenic liver abscess: surgery is now second-line treatmentJames J Mezhir, Yuman Fong, Lindsay M Jacks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularineJulianne L Holleran, Robert A Parise, Erin Joseph, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 12, 2016
Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer PatientsHooman Yarmohammadi, Lynn A Brody, Joseph P Erinjeri, et al.
Annals of Surgery|April 1, 2008
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastasesAnne M Covey, Karen T Brown, William R Jarnagin, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 4, 2011
Pyogenic abscess after hepatic artery embolization: a rare but potentially lethal complicationJames J Mezhir, Yuman Fong, Deborah Fleischer, et al.
Surgical Endoscopy|January 31, 2013
Management of peripancreatic fluid collections following partial pancreatectomy: a comparison of percutaneous versus EUS-guided drainageYong M Kwon, Hans Gerdes, Mark A Schattner, et al.
Pageof 19